LUNG CANCER (LOCALLY ADVANCED OR METASTATIC)

Clinical trials for LUNG CANCER (LOCALLY ADVANCED OR METASTATIC) explained in plain language.

Never miss a new study

Get alerted when new LUNG CANCER (LOCALLY ADVANCED OR METASTATIC) trials appear

Sign up with your email to follow new studies for LUNG CANCER (LOCALLY ADVANCED OR METASTATIC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 3 Not yet finished but already full! 1

New pill targets tough cancers after other treatments fail

Disease control Recruiting now

This early-stage study is testing a new oral drug called VMD-928, both by itself and combined with an existing immunotherapy (pembrolizumab). It is for adults with advanced solid tumors or lymphoma that have progressed despite available treatments. The main goals are to find safe…

Matched conditions: LUNG CANCER (LOCALLY ADVANCED OR METASTATIC)

Phase: PHASE1, PHASE2 • Sponsor: VM Oncology, LLC • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

LUNG CANCER (LOCALLY ADVANCED OR METASTATIC)

Get alerted when new LUNG CANCER (LOCALLY ADVANCED OR METASTATIC) trials appear

New pill targets tough cancers after other treatments fail